In 2023, the import of heterocyclic compounds with an unfused thiazole ring to France stood at approximately 81.712 million US dollars. In 2024, the forecast indicates a growth of 83.313 million US dollars, reflecting a year-on-year increase of 1.96% from 2023. In subsequent years, imports are expected to continue this upward trend, reaching 90.127 million US dollars by 2028. The forecasted compound annual growth rate (CAGR) from 2024 to 2028 is approximately 2.0%.

Future trends to watch include:

The impact of regulatory changes in the EU affecting chemical imports.
Potential advancements in pharmaceutical and industrial applications of thiazole derivatives in France.
Fluctuations in global supply chains and their influence on import volumes and values.